Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
Herpes zoster (HZ) results from waning immunity following childhood infection with varicella zoster virus (VZV) but is preventable by vaccination with recombinant HZ vaccine or live HZ vaccine (two doses or one dose, respectively). Vaccine efficacy declines with age, live HZ vaccine is contraindicat...
Saved in:
Main Authors: | Marta Ulaszewska (Author), Sarah Merelie (Author), Sarah Sebastian (Author), Teresa Lambe (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Herpes zoster vaccination. An update
by: Khairuddin Djawad, et al.
Published: (2022) -
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
by: Katie Ewer, et al.
Published: (2017) -
Single-cycle adenovirus vectors in the current vaccine landscape
by: Michael Barry
Published: (2018) -
Herpes Zoster
by: Hamid Ehsani-Nia, et al.
Published: (2017) -
Vaccine-Associated Herpes Zoster Ophthalmicus and Encephalitis
by: J Gordon Millichap
Published: (2010)